NCT07141706View on ClinicalTrials.gov

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

233

Participants

Timeline

Start Date

September 23, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions

Advanced/Metastatic Solid Tumors

Interventions

DRUG

DB-1317

Administered I.V.

Trial Locations (3)

2031

RECRUITING

AUS01-0, Randwick

22031

NOT_YET_RECRUITING

USA01, Fairfax

78229

NOT_YET_RECRUITING

USA03-0, San Antonio

All Listed Sponsors

lead

DualityBio Inc.

INDUSTRY